Literature DB >> 32519459

Machine Perfusions in Liver Transplantation: The Evidence-Based Position Paper of the Italian Society of Organ and Tissue Transplantation.

Davide Ghinolfi1, Quirino Lai2, Daniele Dondossola3, Riccardo De Carlis4, Marinella Zanierato5, Damiano Patrono6, Stefano Baroni7, Domenico Bassi8, Fabio Ferla4, Andrea Lauterio4, Chiara Lazzeri9, Paolo Magistri10, Fabio Melandro1, Duilio Pagano11, Daniele Pezzati1, Matteo Ravaioli12, Erion Rreka1, Luca Toti13, Alberto Zanella14, Patrizia Burra15, Salvatore Petta16, Massimo Rossi2, Philippe Dutkowski17, Wayel Jassem18, Paolo Muiesan19, Cristiano Quintini20, Markus Selzner21, Umberto Cillo8.   

Abstract

The use of machine perfusion (MP) in liver transplantation (LT) is spreading worldwide. However, its efficacy has not been demonstrated, and its proper clinical use has far to go to be widely implemented. The Società Italiana Trapianti d'Organo (SITO) promoted the development of an evidence-based position paper. A 3-step approach has been adopted to develop this position paper. First, SITO appointed a chair and a cochair who then assembled a working group with specific experience of MP in LT. The Guideline Development Group framed the clinical questions into a patient, intervention, control, and outcome (PICO) format, extracted and analyzed the available literature, ranked the quality of the evidence, and prepared and graded the recommendations. Recommendations were then discussed by all the members of the SITO and were voted on via the Delphi method by an institutional review board. Finally, they were evaluated and scored by a panel of external reviewers. All available literature was analyzed, and its quality was ranked. A total of 18 recommendations regarding the use and the efficacy of ex situ hypothermic and normothermic machine perfusion and sequential normothermic regional perfusion and ex situ MP were prepared and graded according to the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) method. A critical and scientific approach is required for the safe implementation of this new technology.
Copyright © 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2020        PMID: 32519459     DOI: 10.1002/lt.25817

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  6 in total

1.  Viability testing during normothermic machine perfusion requires both hepatocellular and cholangiocellular criteria.

Authors:  Fabio Melandro; Paolo De Simone; Davide Ghinolfi
Journal:  Updates Surg       Date:  2021-01-21

2.  Current practice of normothermic regional perfusion and machine perfusion in donation after circulatory death liver transplants in Italy.

Authors:  Riccardo De Carlis; Andrea Lauterio; Leonardo Centonze; Vincenzo Buscemi; Andrea Schlegel; Paolo Muiesan; Luciano De Carlis
Journal:  Updates Surg       Date:  2022-02-28

3.  Heterogeneous indications and the need for viability assessment: An international survey on the use of machine perfusion in liver transplantation.

Authors:  Damiano Patrono; Davide Cussa; Federica Rigo; Renato Romagnoli
Journal:  Artif Organs       Date:  2021-09-08       Impact factor: 2.663

4.  How useful is the machine perfusion in liver transplantation? An answer from a national survey.

Authors:  Irene Scalera; R De Carlis; D Patrono; E Gringeri; T Olivieri; D Pagano; Q Lai; M Rossi; S Gruttadauria; F Di Benedetto; U Cillo; R Romagnoli; L G Lupo; L De Carlis
Journal:  Front Surg       Date:  2022-09-22

5.  Ex vivo machine perfusion: current applications and future directions in liver transplantation.

Authors:  Julian Michelotto; Joseph M G V Gassner; Simon Moosburner; Vanessa Muth; Madhukar S Patel; Markus Selzner; Johann Pratschke; Igor M Sauer; Nathanael Raschzok
Journal:  Langenbecks Arch Surg       Date:  2020-11-20       Impact factor: 3.445

6.  Quantitative Metabolomics of Tissue, Perfusate, and Bile from Rat Livers Subjected to Normothermic Machine Perfusion.

Authors:  Caterina Lonati; Daniele Dondossola; Laimdota Zizmare; Michele Battistin; Leonie Wüst; Luigi Vivona; Margherita Carbonaro; Alberto Zanella; Stefano Gatti; Andrea Schlegel; Christoph Trautwein
Journal:  Biomedicines       Date:  2022-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.